We are in a strong position to offer upto 90% cost reduction in upstream bioprocessing for vaccine production, biologics manufacturing and cell therapies.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free